Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients

Journal of Endocrinology

Volumn 153, Issue 2, 1997, Pages 307-312

  Geisler, J ^a   Engelsen, B A ^a   Berntsen, H ^a   Geisler, S ^a   Lonning P E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ESTRONE SULFATE; PRASTERONE SULFATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPILEPSY; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0030986568     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1530307     Document Type: Article

References (38)

1. Barrett-Connor E, Khaw KT & Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. New England Journal of Medicine 315 1519-1524.
2. Bolt HM 1979 Metabolism of estrogens, natural and synthetic. Pharmacology and Therapeutics 4 155-181.
3. Burns GRJ 1983 Purification and partial characterization of aryl sulphatase C from human placental microsomes. Biochimica et Biophysics Acta 759 199-204.
4. Connell JMC, Rapeport WG, Beastall GH & Brodie MJ 1984 Changes in circulating androgens during short term carbamazepine therapy. British Journal of Clinical Pharmacology 17 347-351.
5. Conney AH & Klutch A 1963 Increased activity of androgen hydroxylases in liver microsomes of rats pretreated with phenobarbital and other drugs. Journal of Biological Chemistry 238 1611-1617.
6. 3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. Journal of Endocrinology 150 S33-S42.
7. Dibbelt I & Kuss E 1986 Human placental steryl-sulphatase. Biological Chemistry Hoppe-Seyler 367 1223-1229.
8. Dowsett M, Goss PE, Powles TJ, Hutchinson G, Brodie AMH, Jeffcoate SL & Coombes RC 1987 Use of aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Research 47 1957-1961.
9. Edwards OM, Courtenay-Evans RJ, Galley JM, Hunter J & Tait AD 1974 Changes in cortisol metabolism following rifampicin therapy. Lancet ii 549-551.
10. Fehér T & Halmy L 1974 A comparative study of dehydroepiandrosterone and dehydroepiandrosterone sulphate dynamics by the 'urinary' and 'blood approach' under physiological conditions. Acta Endocrinologica 75 314-324.
11. Fehér T & Halmy L 1975 Dehydroepiandrosterone and dehydroepiandrosterone sulfate dynamics in obesity. Canadian Journal of Biochemistry 53 215-222.
12. Fishman J & Hellman L 1973 Comparative fate of estrone and estrone sulfate in man. Journal of Clinical Endocrinology and Metabolism 36 160-164.
13. Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL & Comstock G 1992 Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Research 52 1-4.
14. Kawano J, Kotani T, Ohtaki S, Minamino N, Matsuo H, Oinuma T & Aikawa E 1989 Characterization of rat and human steroid sulphates. Biochimica et Biophysica Acta 997 199-205.
15. Lai AA, Levy RH & Cutler RE 1978 Time-course of interaction between carbamazepine and clonazepam in normal man. Clinical Pharmacology and Therapeutics 24 316-323.
16. Longcope C 1972 The metabolism of estrone sulfate in normal males. Journal of Clinical Endocrinology 34 113-122.
17. 3H-estrone. Journal of Clinical Endocrinology and Metabolism 38 602-607.
18. Lønning PE & Kvinnsland S 1988 Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs 35 685-710.
19. Lnning PE, Kvinnsland S, Thorsen T & Ueland PM 1987 Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Clinical Pharmacokinetics 13 393-406.
20. Lønning PE, Johannessen DC, Thorsen T & Ekse D 1989a Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition. Journal of Steroid Biochemistry 33 541-545.
21. Lønning PE, Bakke P, Thorsen T, Olsen B & Gulsvik A 1989b Plasma levels of estradiol, estrone, estrone sulfate and sex hormone binding globulin in patients receiving rifampicin. Journal of Steroid Biochemistry 33 631-635.
22. Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB & Hall K 1995 Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-I in postmenopausal breast cancer patients. Clinical Endocrinology 42 23-30.
23. MacIndoe JH, Woods G, Jeffries L & Hinkhouse M 1988 The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology 123 1281-1287.
24. Majewska MD, Demirgören S, Spivak CE & London ED 1990 The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAα receptor. Brain Research 526, 143-146.
25. Mattson RH & Cramer JA 1985 Epilepsy, sex hormones, and antiepileptic drugs. Epilepsia 26, S40-S51.
26. Mellon SH 1994 Neurosteroids: biochemistry, modes of action, and clinical relevance. Journal of Clinical Endocrinology and Metabolism 78 1003-1008.
27. Morales AJ, Nolan JJ, Nelson JC & Yen SSC 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. Journal of Clinical Endocrinology and Metabolism 78 1360-1367.
28. Murray M, Cantrill E & Farrell GC 1993 Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide. Journal of Pharmacology and Experimental Therapeutics 265 477-481.
29. Orentreich N, Brind JL, Rizer RL & Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism 59 551-555.
30. Purohit A, Dauvois S, Parker MG, Potter BVL, Williams GJ & Reed MJ 1994 The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells. Journal of Steroid Biochemistry and Molecular Biology 50 101-104.
31. Rapeport WG, McInnes GT, Thompson GG, Forrest G, Park BK & Brodie MJ 1983 Hepatic enzyme induction and leucocyte delta aminolaevulinic acid synthase activity: studies with carbamazepine. British Journal of Clinical Pharmacology 16 133-137.
32. Roberts KD, Rochefort JG, Bleau G & Chapdelaine A 1980 Plasma estrone sulfate levels in postmenopausal women. Steroids 35 179-187.
33. Rosenfeld RS, Hellman L & Gallagher TF 1972 Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate. Journal of Clinical Endocrinology and Metabolism 35 187-193.
34. Ruder HJ, Loriaux L & Lipset MB 1972 Estrone-sulfate: production rate and metabolism in man. Journal of Clinical Investigation 51 1020-1033.
35. Santen R & Samojlik E 1979 Medical adrenalectomy for treatment of metastatic breast carcinoma. In Breast Cancer: Advances in Research and Treatment, vol. 3, pp 79-115. Ed.WL McGuire. New York: Plenum Press.
36. Santner SJ, Feil PD & Santen RJ 1984 In situ estrogen production via the estrone sulfate pathway in breast tumors; relative importance versus the aromatase pathway. Journal of Clinical Endocrinology and Metabolism 59 29-33.
37. Santner SJ, Leszcynski D, Wright C, Manni A, Feil D & Santen RJ 1986 Estrone sulfate: a potential source of estradiol in human breast cancer tissue. Breast Cancer Research and Treatment 7 35-44.
38. Wilkinson GR & Shand DG 1975 Commentary: a physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18 377-390.